Monografie
Mechanism of dendritic cell-based vaccination against Leishmania major
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Diss., 2013
- Identifier
-
1030475601
- Thema
-
Leishmania ; Leishmania major ; Immunologie ; Immunsystem ; Impfung ; Dendritische Zelle ; Makrophage ; Interferon ; Interleukin 12; Hochschulschrift
- Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Schnitzer, Johannes K.
- Moll, Heidrun
Ähnliche Objekte (12)
Mechanism of dendritic cell-based vaccination against Leishmania major : = Mechanismus der auf dendritischen Zellen beruhenden Impfung gegen Leishmania major
Current status of dendritic cell-based tumor vaccination
Processing of Leishmania dononvani by human dendritic cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Dendritic Cell-Mediated Vaccination Relies on Interleukin-4 Receptor Signaling to Avoid Tissue Damage after Leishmania major Infection of BALB/c Mice
Die Interaktion muriner bone marrow derived dendritic cells mit Leishmania major
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Mechanism of dendritic cell-based vaccination against Leishmania major : = Mechanismus der auf dendritischen Zellen beruhenden Impfung gegen Leishmania major
Current status of dendritic cell-based tumor vaccination
Processing of Leishmania dononvani by human dendritic cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Dendritic Cell-Mediated Vaccination Relies on Interleukin-4 Receptor Signaling to Avoid Tissue Damage after Leishmania major Infection of BALB/c Mice
Die Interaktion muriner bone marrow derived dendritic cells mit Leishmania major
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Mechanism of dendritic cell-based vaccination against Leishmania major : = Mechanismus der auf dendritischen Zellen beruhenden Impfung gegen Leishmania major
Current status of dendritic cell-based tumor vaccination
Processing of Leishmania dononvani by human dendritic cells
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Dendritic Cell-Mediated Vaccination Relies on Interleukin-4 Receptor Signaling to Avoid Tissue Damage after Leishmania major Infection of BALB/c Mice
Die Interaktion muriner bone marrow derived dendritic cells mit Leishmania major
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies